FGAM
IMMU

Financial Gravity Asset Management’s Immunomedics Inc IMMU Stock Holding History

Financial Gravity Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$1K Buy
+24
New +$568 ﹤0.01% 1322

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Financial Gravity Asset Management's IMMU Position: Q3 2018 in Review

Financial Gravity Asset Management opened a new position in Immunomedics Inc (IMMU) in Q3 2018: 24 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1322 among its holdings.

207 funds tracked by Wall St. Rank hold IMMU as of Q3 2018.

  • Financial Gravity Asset Management held 24 shares of Immunomedics Inc worth $1K as of Q3 2018.
  • Immunomedics Inc was a new Financial Gravity Asset Management position in Q3 2018.
  • Immunomedics Inc made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q3 2018, its #1322 holding.
  • 207 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2018.

Based on Financial Gravity Asset Management's 13F filing for Q3 2018, filed 31 Oct 2018.